Table 2.
Correlations between CAF GPC3 expression and clinicopathological characteristics in GC.
| Parameters | No | CAF GPC3 expression |
p Value | |
|---|---|---|---|---|
| Low (n = 25) | High (n = 25) | |||
| Age (years) | .265 | |||
| <60 | 27 | 14 | 11 | |
| ≥60 | 23 | 9 | 14 | |
| Gender | .561 | |||
| Male | 19 | 8 | 11 | |
| Female | 31 | 17 | 14 | |
| Differentiation grade | .769 | |||
| Well/moderate | 18 | 8 | 10 | |
| Poor/undifferentiated | 32 | 17 | 15 | |
| Tumour size (cm) | .778 | |||
| <5 | 24 | 13 | 11 | |
| ≥5 | 26 | 12 | 14 | |
| TNM stage | .021 | |||
| I/II | 29 | 19 | 10 | |
| III/IV | 21 | 6 | 15 | |
| CPS score | .762 | |||
| <5 | 34 | 18 | 16 | |
| ≥5 | 16 | 7 | 9 | |
| MSI/MMR | .417 | |||
| pMMR/MSI-L/MSS | 43 | 23 | 20 | |
| dMMR/MSI-H | 7 | 2 | 5 | |